NUPATHE

nupathe-logo

NuPathe Inc. is a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product candidate, NP101, is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two proprietary product candidates based on its LADโ„ข, or Long-Acting Delivery, biodegradable implant technology that allows deliver... y of therapeutic levels of medication over a period of months with a single dose. NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery. NP202, for the long-term treatment of schizophrenia and bipolar disorder, is being developed to address the long-standing problem of patient noncompliance by providing three months of continuous delivery of risperidone, an atypical antipsychotic. NuPathe is actively seeking partnerships to maximize the commercial potential for its product candidates in the U.S. and territories throughout the world.

#SimilarOrganizations #People #Financial #Website #More

NUPATHE

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2005-01-01

Address:
Malvern, Pennsylvania, United States

Country:
United States

Website Url:
http://www.nupathe.com

Total Employee:
11+

Status:
Active

Contact:
4845670136

Total Funding:
101.56 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API WordPress Font Awesome Domain Not Resolving Euro IPv6 Cloudflare


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

iveric-bio-logo

IVERIC bio

IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.


Current Advisors List

jeanne-cunicelli_image

Jeanne Cunicelli Boards of Directors @ NuPathe
Board_member

Current Employees Featured

not_available_image

Mark W. Pierce
Mark W. Pierce Vice President and Chief Scientific Officer @ NuPathe
Vice President and Chief Scientific Officer

jerry-mclaughlin_image

Jerry McLaughlin
Jerry McLaughlin Senior Vice President and Chief Commercial Officer @ NuPathe
Senior Vice President and Chief Commercial Officer

Founder


terri-sebree_image

Terri Sebree

Stock Details


Company's stock symbol is NASDAQ:PATH

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - NuPathe

birchmere-ventures_image

Birchmere Ventures

Birchmere Ventures investment in Debt Financing - NuPathe

bay-city-capital_image

Bay City Capital

Bay City Capital investment in Series B - NuPathe

birchmere-ventures_image

Birchmere Ventures

Birchmere Ventures investment in Series B - NuPathe

sr-one_image

SR One

SR One investment in Series B - NuPathe

quaker-bioventures_image

Quaker BioVentures

Quaker BioVentures investment in Series B - NuPathe

battelle-ventures_image

Battelle Ventures

Battelle Ventures investment in Series B - NuPathe

bioadvance_image

BioAdvance

BioAdvance investment in Series B - NuPathe

safeguard-scientifics_image

Safeguard Scientifics

Safeguard Scientifics investment in Series B - NuPathe

safeguard-scientifics_image

Safeguard Scientifics

Safeguard Scientifics investment in Series A - NuPathe

Official Site Inspections

http://www.nupathe.com Semrush global rank: 5.77 M Semrush visits lastest month: 1.45 K

  • Host name: 172.67.175.172
  • IP address: 172.67.175.172
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "NuPathe" on Search Engine